Austin · Texas
Austin device startups often draw as much on software and electronics talent as on clinical research. Robert Knechtel, a registered patent attorney who is also a physician and engineer, helps those teams claim what is inventive about their technology in terms that survive examination and later diligence.
Austin's device sector has produced companies that went on to be acquired by large strategic buyers. ArthroCare, based in Austin, developed radiofrequency Coblation systems used in soft-tissue surgery across sports medicine and ear, nose and throat procedures, and it was acquired by Smith & Nephew in 2014. Apollo Endosurgery, also Austin-based, built less invasive gastrointestinal devices and was acquired by Boston Scientific in April 2023, giving the buyer an entry into endobariatric therapy. Abbott's neuromodulation business lists an Austin address on its U.S. customer contact page.
Much of the current pipeline runs through The University of Texas at Austin. Texas Health Catalyst, part of the Office of Innovation and Entrepreneurship at Dell Medical School, supports projects in therapeutics, diagnostics, medical devices and digital health with mentoring from clinical, regulatory, intellectual property and reimbursement advisors, along with seed funding. Discovery to Impact, the university's commercialization office, handles invention disclosures, patent protection and licensing, supports startups through the UT Seed Fund, and in late 2025 opened UT Innovation Labs, a wet lab facility in North Austin for early-stage health and life science companies. The Austin Technology Incubator, founded in 1989 and affiliated with the university, includes a life science track that helps teams prepare medical technologies for clinical evaluation.
On the industry side, the Texas Healthcare and Bioscience Institute, founded in 1996 and headquartered in Austin, serves as the statewide trade association and public policy voice for healthcare and bioscience, including medical device innovation. BioAustinCTX brings together the Central Texas life science community around collaboration and investment.
For patent strategy, Austin's engineering culture tends to produce devices whose value lies in sensing, signal processing and software as much as in mechanical design. Those inventions can be strong, but claims written around data analysis alone may face eligibility challenges, so applications should explain the technical problem solved and the device-level result. And because several Austin device companies have ended in acquisition, portfolios benefit from being built with diligence in mind: clean assignments from every inventor, recorded licenses for university technology, and claims mapped to the products that actually generate revenue.
Patent Strategy Considerations
USPTO examiners apply the Alice/Mayo framework described in MPEP 2106, and claims framed as collecting and analyzing data can be rejected as abstract ideas. Describing the specific sensor configuration, the technical improvement in device operation and the resulting clinical or physical output gives the application a firmer footing, and it should be built into the specification from the first filing.
Companies licensing from Discovery to Impact should confirm the licensed patent families, field of use, sublicensing rights and prosecution control, and should check whether federally funded research brings Bayh-Dole obligations. Improvements the startup develops after licensing are generally best captured in separate company-owned applications so that the core asset base is not wholly dependent on the license.
Acquirers and later-stage investors commonly review chain of title, inventor assignments, license terms and whether issued claims cover the marketed product. Recording assignments at the USPTO, documenting contractor and consultant contributions, and periodically comparing claims to the current product design make that review faster and reduce the risk of surprises late in a transaction.
How Engagements Work
Knechtel Law Group is based in Carefree, Arizona. Patent prosecution and counseling before the U.S. Patent and Trademark Office is federal practice, and engagements with Austin-area companies are handled directly by senior counsel by video and in person as needed. Matters that turn on state law may call for local counsel.
Request a Confidential ConsultationCommon Questions
No. Practice before the USPTO is governed by federal law, and registered patent attorneys can represent applicants anywhere in the United States. Questions arising under Texas law, such as contract or employment disputes, may require Texas-licensed counsel, and we can work with local counsel where needed.
Before any public disclosure, including demo days, publications and investor presentations without confidentiality protection. A provisional application gives a filing date, but it lasts 12 months and that period cannot be extended; a nonprovisional application must be filed within that window to claim its benefit, subject only to a narrow restoration petition. A provisional that describes the invention thoroughly is far more useful than a brief placeholder.
Discuss Your Portfolio
Schedule a confidential consultation to discuss your technology, your existing portfolio, and your plans.
Request a Confidential Consultation